BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29523615)

  • 1. Treatment of relapsed multiple myeloma complicated by cardiac extramedullary plasmacytoma with D-PACE chemotherapy.
    Toocheck C; Pinkhas D
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29523615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Painful Nodules in a Patient With Multiple Myeloma.
    Tsui EW; Choi E; Meehan KR
    JAMA Oncol; 2017 Oct; 3(10):1423-1424. PubMed ID: 28796873
    [No Abstract]   [Full Text] [Related]  

  • 3. [A clinical analysis of 25 cases of multiple myeloma complicated by extramedullary plasmacytomas].
    Zhong YP; Chen SL
    Zhonghua Nei Ke Za Zhi; 2009 May; 48(5):396-8. PubMed ID: 19615158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
    Rosiñol L; Beksac M; Zamagni E; Van de Donk NWCJ; Anderson KC; Badros A; Caers J; Cavo M; Dimopoulos MA; Dispenzieri A; Einsele H; Engelhardt M; Fernández de Larrea C; Gahrton G; Gay F; Hájek R; Hungria V; Jurczyszyn A; Kröger N; Kyle RA; Leal da Costa F; Leleu X; Lentzsch S; Mateos MV; Merlini G; Mohty M; Moreau P; Rasche L; Reece D; Sezer O; Sonneveld P; Usmani SZ; Vanderkerken K; Vesole DH; Waage A; Zweegman S; Richardson PG; Bladé J
    Br J Haematol; 2021 Aug; 194(3):496-507. PubMed ID: 33724461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma.
    Griffin PT; Ho VQ; Fulp W; Nishihori T; Shain KH; Alsina M; Baz RC
    Cancer; 2015 Oct; 121(20):3622-30. PubMed ID: 26149422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
    Jiménez-Segura R; Granell M; Gironella M; Abella E; García-Guiñón A; Oriol A; Cabezudo E; Clapés V; Soler JA; Escoda L; López-Pardo J; Fernández de Larrea C; Cibeira MT; Tovar N; Isola I; Bladé J; Rosiñol L;
    Eur J Haematol; 2019 May; 102(5):389-394. PubMed ID: 30719772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bortezomib-based combination therapy for relapsed or refractory multiple myeloma].
    Yuan ZG; Hou J; Wang DX; Fu WJ; Chen YB; Xi H
    Zhonghua Nei Ke Za Zhi; 2008 Feb; 47(2):102-6. PubMed ID: 18683793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophagocytic relapsed intramedullary plasmacytoma.
    Mouhieddine TH; Barlogie B; Teruya-Feldstein J
    Int J Hematol; 2020 Jun; 111(6):888-890. PubMed ID: 31900879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents.
    Ronchetti AM; Isnard F; Buffet M; Coman T; Gorin NC; Coppo P; Garderet L; Malak S
    Leuk Lymphoma; 2013 May; 54(5):1117-9. PubMed ID: 23035656
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical analysis of multiple myeloma with extramedullary plasmacytomas].
    Li X; Sun WJ; Chen SL; Zhong YP; An N; Hu Y; Zhang JJ; Liu XH
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(12):838-41. PubMed ID: 22781459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual presentation of extramedullary plasmacytoma occurring sequentially in the testis, subcutaneous tissue, and heart.
    Fernandez LA; Couban S; Sy R; Miller R
    Am J Hematol; 2001 Jul; 67(3):194-6. PubMed ID: 11391718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients.
    Dadacaridou M; Papanicolaou X; Maltesas D; Megalakaki C; Patos P; Panteli K; Repousis P; Mitsouli-Mentzikof C
    J BUON; 2007; 12(1):41-4. PubMed ID: 17436400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D(T)PACE as salvage therapy for aggressive or refractory multiple myeloma.
    Gerrie AS; Mikhael JR; Cheng L; Jiang H; Kukreti V; Panzarella T; Reece D; Stewart KA; Trieu Y; Trudel S; Chen CI
    Br J Haematol; 2013 Jun; 161(6):802-10. PubMed ID: 23594335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cranial nerve palsy in multiple myeloma and solitary plasmacytoma.
    Kashyap R; Kumar R; Kumar S
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):251-5. PubMed ID: 21114773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Course of a Patient With Kidney Failure Due to Isolated Bilateral Renal Extramedullary Plasmacytomas.
    Lawrence BJ; Petersen EL; Riches WG; Pfeiffer DC
    Am J Kidney Dis; 2018 Nov; 72(5):752-755. PubMed ID: 29885924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide, dexamethasone, cytarabine, and cisplatin in vincristine, doxorubicin, and dexamethasone-refractory myeloma.
    Barlogie B; Velasquez WS; Alexanian R; Cabanillas F
    J Clin Oncol; 1989 Oct; 7(10):1514-7. PubMed ID: 2778481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory plasmablastic type myeloma with multiple extramedullary plasmacytomas and massive myelomatous effusion: remarkable response with a combination of thalidomide and dexamethasone.
    Nakazato T; Suzuki K; Mihara A; Sanada Y; Kakimoto T
    Intern Med; 2009; 48(20):1827-32. PubMed ID: 19834276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of extramedullary plasmablastic plasmacytoma successfully treated using a combination of thalidomide and dexamethasone and a review of the medical literature.
    Sekiguchi Y; Asahina T; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Komatsu N; Noguchi M
    J Clin Exp Hematop; 2013; 53(1):21-8. PubMed ID: 23801130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloma presenting during pregnancy.
    Smith D; Stevens J; Quinn J; Cavenagh J; Ingram W; Yong K
    Hematol Oncol; 2014 Mar; 32(1):52-5. PubMed ID: 23996410
    [No Abstract]   [Full Text] [Related]  

  • 20. Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents.
    Chen CI; Masih-Khan E; Jiang H; Rabea A; Cserti-Gazdewich C; Jimenez-Zepeda VH; Chu CM; Kukreti V; Trudel S; Tiedemann R; Tsang R; Reece DE
    Br J Haematol; 2013 Aug; 162(4):483-8. PubMed ID: 23772701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.